Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...

Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...

A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...

Shares of Waters Corp. slid 3.16% to $287.53 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.01% to 6,296.79 and Dow Jones ...

Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...

Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

Waters Corp.'s $17.5B merger with BD Biosciences aims to double revenue but raises risks. Read here for an investment ...

BD and Waters announced an agreement to create a new life science and diagnostics leader through a business combination.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Waters Corp. closed 29.90% below its 52-week high of $423.56, which the company reached on January 30th.